Ref ID: 19412
E. Shagdileeva,1 S. N. Khostelidy,1 E. R. Raush,1 E. N. Shaidaeva,2
I. Samorodova,2 A. V. Klimovich,2 N. Kotova,2 J. M. Melehina,1
T. S. Bogomolova,1 I. V. Vybornova1 and N. N. Klimko1
1North-Western State Medical University named after I.I.
Mechnicov, Saint-Petersburg, Russian Federation and 2City
hospital 31, Saint-Petersburg, Russian Federation
Full conference title:
6th Trends in Medical Mycology 2013
Date: 11 October 2014
Objectives Invasive candidiasis (IA) and aspergillosis (IA) are lead-
ing causes of morbidity and mortality in haematological patients.
Publications about combination of iC and IA in haematological
patients are limited.
Methods EORTS/MSG criteria (2008) of diagnosis of IFD and treat-
ment response were used.
Results 58 years old male was hospitalized in the City hospital ’31,
Saint-Petersburg, at 06.08.2012 with non-Hodgkin’s lymphoma,
IVB. He received cytostatic chemotherapy R-DA-EPOCH. The refrac-
tory to antibacterials febrile neutropenia started after a week of che-
motherapy. C krusei was identified in cultures of peripheral blood and
central venous catheter (CVC) samples. Treatment with amphotericin
B 50 mg/day was started, CVC was replaced. At the same time the
necrotic changes of nasal soft tissues developed. On computerized
tomography (CT) scans there were symptoms of rhinosinusitis and
pulmonary infiltrates in the upper lobes of the lungs. Necrosectomy
of nasal soft tissues was performed. In microscopy of tissue specific
hyphae were seen. A.flavus was revealed in culture of this tissue and
bronchoalveolar lavage fluid. The treatment was changed to caspo-
fungin 50 mg/day and voriconazole 400 mg/day.
A complete effect of the treatment of invasive candidosis (C.krusei)
and invasive aspergillosis (A. flavus) was achieved. Duration of anti-
fungal therapy was 98 days. There were no side effects of caspofun-
gin and voriconazole.
Conclusion Combination therapy with caspofungin and voriconaz-
ole can be successful in the treatment of combination of invasive
candidiasis and aspergillosis in haematological patients.
Abstract Number: p171
Conference Year: 2013
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
C Gutierrez Perez1*, S Dhingra1,2, SM Kwansy3, TJ Opperman3, RA Cramer1
PC Chatterjee1*, WC Chiu1, EBB Burgener2, PLB Bollyky3, JH Hsu1
AS Serris1*, FU Uhel2, GMB Martin-Blondel3, OL Lambotte4, MEB Bougnoux5, EL Litvinova6, AO Ouedrani7, CR Rouzaud1, VB Bedarida8, JHR Raphalen9, FL Lanternier1,10
ZA Lewis1, RB Meagher2*, S Ambati2, X Lin1
QJ Choudhury1*, S Ambati2, X Lin1, ZA Lewis1, RB Meagher2
M James1*, KW Liu1, E Vesley1, T Hohl2, RA Cramer1
D Luptakova1, RH Patil1,2, V Havlicek1,2*
EI Matthaiou1*, W Chiu1, C Conrad2, J Hsu1
H Kamboj*, M Vijay, L Gupta, P Vijayaraghavan
S Hartung1,2*, TNM Hoang1,2*, Z Cseresnyes3*, N Schuck1, K Rennert4,5, F Klos6, AS Mosig5,7, MT Figge3,8, M von Lilienfeld-Toal1,2
* Authors 1, 2 and 3 contributed equally